They are TMED2 (NM_006815.3, transmembrane p24 trafficking protein 2), GTPBP10 (NM_033107.3, GTP binding protein 10), GOLT1B (NM_016072.4, golgi transport 1B), SPRYD3 (NM_032840.2, SPRY domain containing 3), ZNF503 (NM_032772.5, zinc finger protein 503), TMEM41B (NM_015012.3, transmembrane protein 41B) and CASC4 (NM_177974.2, Cancer susceptibility candidate 4) (Table S12). This evidence concerns the gene SPRYD3 and cancer.